Ocular Therapeutix™ To Present Pre-Clinical and Clinical Data at the 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

April 16, 2023

https://www.globenewswire.com/news-release/2023/04/14/2647340/0/en/Ocular-Therapeutix-To-Present-Pre-Clinical-and-Clinical-Data-at-the-2023-Association-for-Research-in-Vision-and-Ophthalmology-ARVO-Annual-Meeting.html

BEDFORD, Mass., April 14, 2023 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announced multiple scientific presentations at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held April 23 – 27 in New Orleans, Louisiana.

Read more at globenewswire.com

Related news for (OCUL)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.